- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
India Launches a New Lab for HIV Research
14 August 2012 3:17 pm
NEW DEHLI—On Monday, India opened a $12 million, government-backed laboratory whose mission is to create a new vaccine against HIV. The HIV Vaccine Translational Research Laboratory, which aims to recruit about 30 scientists, is embedded within the Translational Health Science and Technology Institute, a $200 million facility under development on the outskirts of New Delhi. It will work in collaboration with the New York based-International AIDS Vaccine Initiative (IAVI); operating costs will be shared equally.
India has the world's third largest burden of AIDS, despite the fact that "HIV infections have declined by 56% during the last decade, from 270,000 in 2000 to 120,000 in 2009," says India’s health minister Ghulam Nabi Azad. He says there is a desperate need for a vaccine against HIV.
"Designing a new broad-spectrum HIV vaccine will be the mandate of this new lab," says Margaret G. McGlynn, CEO of IAVI. The goal is achievable, she says: "Researchers have long known that after a few years of infection, a minority of HIV-positive people produce antibodies that can neutralize a broad spectrum of HIV variants." The aim is to find a suitable broad spectrum antibody for the purpose. McGlynn says the plan is to make and test a vaccine in India, which she says is "suitably placed with its talented scientific manpower, well-established pharma industry, and a huge commitment from the government."